Laissy J P, Soyer P, Tebboune D, Tiah D, Hvass U, Menu Y
Department of Radiology, Hôpital Bichat, Paris, France.
Eur J Radiol. 1995 May;20(1):1-8. doi: 10.1016/0720-048x(95)00620-6.
A prospective study was performed to evaluate the efficacy of a gadolinium-chelate-enhanced MR angiography (MRA) using a coronal acquisition in the preoperative assessment of aneurysms of the abdominal aorta (AAA). Twenty patients with AAA were explored with MR using a two-dimensional (2D) time-of-flight MRA technique with a coronal acquisition, before and after intravenous administration of 0.1 mmol/kg of a gadolinium-chelate. Gadolinium-chelate-enhanced MRA with a coronal acquisition decreased deleterious saturation effects within aorta and iliac arteries in 16 of 20 patients (80%) and improved the overall quality of the images of the upper and lower parts of the AAA (i.e. extent of the aneurysm). Furthermore, gadolinium-chelate-enhanced MRA with a coronal acquisition allowed a better differentiation between slow flow and mural thrombus. Gadolinium-chelate-enhanced MRA had a sensitivity of 100% and a specificity of 96% for evaluation of renal artery involvement, and a sensitivity of 93% and a specificity of 100% for iliac artery involvement. The results of this study show that gadolinium-chelate-enhanced MRA obtained with a coronal acquisition is efficacious for the preoperative assessment of AAA.
进行了一项前瞻性研究,以评估钆螯合物增强磁共振血管造影(MRA)采用冠状位采集在腹主动脉瘤(AAA)术前评估中的疗效。20例AAA患者在静脉注射0.1 mmol/kg钆螯合物前后,使用二维(2D)时间飞跃MRA技术并采用冠状位采集进行磁共振检查。钆螯合物增强的冠状位MRA使20例患者中的16例(80%)腹主动脉和髂动脉内的有害饱和效应降低,并改善了AAA上下部分图像的整体质量(即动脉瘤范围)。此外,钆螯合物增强的冠状位MRA能更好地区分缓慢血流和壁内血栓。钆螯合物增强MRA评估肾动脉受累的敏感性为100%,特异性为96%,评估髂动脉受累的敏感性为93%,特异性为100%。本研究结果表明,采用冠状位采集获得的钆螯合物增强MRA对AAA的术前评估有效。